7-150950336-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.2230C>T(p.Arg744Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000238.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2230C>T | p.Arg744Ter | stop_gained | 9/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.2230C>T | p.Arg744Ter | stop_gained | 9/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461218Hom.: 0 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 726942
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Long QT syndrome 2 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | May 23, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Blueprint Genetics | Aug 29, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Jun 25, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 06, 2021 | - - |
Long QT syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 15, 2023 | This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 11802537, 19841298, 26704558). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg744*) in the KCNH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNH2 are known to be pathogenic (PMID: 10973849, 19862833). ClinVar contains an entry for this variant (Variation ID: 180383). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | research | Dept of Medical Biology, Uskudar University | Jan 08, 2024 | Criteria: PVS1_Strong, PP1_Strong, PM2 - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2024 | Reported in patients with LQTS, prolonged QT intervals, and an individual with sudden unexpected death in epilepsy (PMID: 19841298, 22338672, 26704558); also identified in patients with LQTS referred for genetic testing at GeneDx; Segregates with disease in many affected individuals from several families in published literature (PMID: 22338672, 11802537); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 19716085, 28363160, 11802537, 22338672, 11854117, 26704558, 28775708, 25525159, 31727422, 33304416, 33013630, 31018519, 34546463, 36861347, 19841298) - |
Congenital long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 25, 2018 | The p.Arg744X variant in KCNH2 has been reported in 1 Caucasian individual with sudden unexpected death in epilepsy (Bagnall 2016), 8 individuals with Long QT syndrome (Ko 2001, Moss 2002, Schwartz 2009, Kapplinger 2009, Crotti 2012), and 1 individual with LQTS and Charcot-Marie-Tooth disease, who also carried a dup of 17p11.2 (Losito 2009). This variant segregated with LQTS in 13 relatives from multiple families. This variant has also been reported in ClinVar (Variation ID 180383) and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 744, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the KCNH2 gene is an established disease mechanism in LQTS. In summary, this variant meets criteria to be classified as pathogenic for LQTS in an autosomal dominant manner based upon segregation studies, absence from controls, and predicted impact on protein. ACMG/AMP Criteria applied: PVS1, PP1_Strong, PM2, PS4_Moderate (Richards 2015). - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2020 | The p.R744* pathogenic mutation (also known as c.2230C>T), located in coding exon 9 of the KCNH2 gene, results from a C to T substitution at nucleotide position 2230. This changes the amino acid from an arginine to a stop codon within coding exon 9. This alteration has been detected in individuals with long QT syndrome (LQTS) as well as in LQTS genetic testing cohorts, and has shown segregation with disease in two families (Ko YL et al. J. Formos. Med. Assoc., 2001 Nov;100:767-71; Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303; Schwartz PJ et al. Circulation, 2009 Nov;120:1761-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at